... non-immunocompromised patient with chronic lung disease It has however, been suggested that herpetic respiratory infections are commoner in patients with underlying lung disease [3] HSV causes a latent infection ... have been intubated [1,2,4-6] The virus source is usually from the oropharynx Several patterns of pulmonary damage can occur, with tracheobronchitis the most common manifestation Ulceration of the ... exacerbations of COPD may be underestimated Diagnosis may be considered in patients with chronic lung disease, especially during exacerbations of COPD who are not responding to conventional treatment...
... chronic obstructivepulmonarydisease worldwide Monaldi Archives for Chest Disease 2001; 56: 261-264 Anto JM, Vermeire P, Vestbo J, Sunyer J Epidemiology of chronic obstructivepulmonarydisease ... Int J Med Sci 2007, disease [5] How we account for these increases in rates of COPD? Chronic obstructivepulmonarydisease (COPD) is a condition characterized by progressive ... Medicine 2003; 97(suppl C): S1-S2 Faulkner MA, Hilleman DE The economic impact of chronic obstructivepulmonarydisease Expert Opinion on Pharmacotherapy 2002; 3: 219-228 Izquierdo JL The burden of...
... activity in chronic obstructivepulmonarydisease N Engl J Med exercise intolerance in chronic obstructivepulmonarydisease Am J Respir Crit Care Med L- chronic obstructivepulmonarydisease Eur Respir ... chronic obstructivepulmonarydisease N Engl J Med parenchyma in COPD: role of T cells Chest HT E Wright JL, Levy RD, Churg A Pulmonary hypertension in chronic obstructivepulmonary disease: ... exposure and risk of chronic obstructivepulmonarydisease Eur Respir J 43 MacNee W Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructivepulmonarydisease Proc Am Thorac Soc...
... with chronic obstructivepulmonarydisease Thorax 1996, 51:39-43 Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, Plaza V, Prieto L, Anto JM: Chronic obstructivepulmonarydisease stage ... chronic obstructivepulmonarydisease Arch Intern Med 1984, 144:1613-1619 McSweeny J, Grant I, Heaton RK, Adams KM, Timms RM: Life quality of patients with chronic obstructivepulmonarydisease ... the diagnosis, management, and prevention of chronic obstructivepulmonarydisease NHLBI/WHO global iniciative for chronic obstructive lung disease (GOLD) workshop summary Am J Respir Crit Care...
... obstructivepulmonary disease: a randomized trial Ann Intern Med 2007, 146:545-555 30 Ernst P, Gonzalez AV, Brassard P, Suissa S: Inhaled corticosteroid use in chronic obstructivepulmonarydisease ... Zielinski J, Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructivepulmonary disease: GOLD executive summary Am ... chronic obstructivepulmonarydisease Thorax 2005, 60:925-931 Andersson F, Borg S, Jansson SA, Jonsson AC, Ericsson A, Prütz C, Rönmark E, Lundbäck B: The costs of exacerbations in chronic obstructive...
... MA, Vollenweider D, Latshang T, Steurer J, Steurer-Stey C: Exacerbations of chronic obstructivepulmonary disease: when are antibiotics indicated? A systematic review Respiratory research 2007, ... Hershfield ES, Harding GK, Nelson NA: Antibiotic therapy in exacerbations of chronic obstructivepulmonarydisease Annals of Internal Medicine 1987, 106(2):196-204 Publish with Bio Med Central...
... J: The natural history of chronic obstructivepulmonarydisease Eur Respir J 2006, 27(3):627-643 Agusti A: Systemic effects of chronic obstructivepulmonary disease: what we know and what we ... between asthma and chronic obstructivepulmonarydisease Curr Opin Pulm Med 2008, 14(1):31-38 Kalsheker N, Chappell S: The new genetics and chronic obstructivepulmonarydisease Copd 2008, 5(4):257-264 ... of smokers with chronic obstructivepulmonarydisease Am J Respir Crit Care Med 2007, 175(6):577-586 Wood AM, Stockley RA: The genetics of chronic obstructivepulmonarydisease Respir Res 2006,...
... chronic obstructivepulmonarydisease N Engl J Med 2007, 356(8):775-789 Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA, INSPIRE Investigators: The prevention of chronic obstructive ... and Glaxo- Global Strategy for the Diagnosis, Management, and Prevention of Chronic ObstructivePulmonaryDisease [http:// www.goldcopd.com] Calverley PM, Anderson JA, Celli B, Calverley PM, ... provided a strong evidence base for the role of drug treatment in the management of chronic obstructivepulmonarydisease (COPD) [1] The efficacy of inhaled corticosteroid/long-acting b-agonist (ICS/LABA)...
... Respir J 2004, 24(6):896-897 NICE: Chronic obstructivepulmonary disease: national clinical guideline for management of chronic obstructivepulmonarydisease in adults in primary and secondary ... exacerbations of chronic obstructivepulmonarydisease Clin Infect Dis 2004, 39(7):980-986 Saint S, Bent S, Vittinghoff E, Grady D: Antibiotics in chronic obstructivepulmonarydisease exacerbations ... chronic obstructivepulmonarydisease Am J Respir Crit Care Med 2001, 164(9):1618-1623 Miravitlles M, Mayordomo C, Artes M, Sanchez-Agudo L, Nicolau F, Segu JL: Treatment of chronic obstructive pulmonary...
... the diagnosis, management, and prevention of chronic obstructivepulmonarydisease NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am J Respir Crit Care ... Pauwels RA: Chronic obstructivepulmonary disease: molecular and cellular mechanisms Eur Respir J 2003, 22:672-688 Jeffery PK: Remodeling in asthma and chronic obstructive lung disease Am J Respir ... management of chronic obstructivepulmonarydisease (COPD) The European Respiratory Society Task Force Eur Respir J 1995, 8:1398-1420 Global initiative for Chronic Obstructive Lung Disease NIH Definitions...
... Collaborating Centre for Chronic Conditions: Chronic obstructivepulmonarydisease National clinical guideline on management of chronic obstructivepulmonarydisease in adults in primary and secondary ... Respiratory Research 2008, 9:62 Background Chronic obstructivepulmonarydisease (COPD) is a growing burden to patients and the National Health Service Disease progression is preventable by early detection ... tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD Chest 2005, 127:809-817 Celli B: Chronic ObstructivePulmonaryDisease From unjustified nihilism to evidence-based...
... chronic obstructivepulmonarydisease N Engl J Med 2004, 350:2645-2653 Sin DD, Man SF: Why are patients with chronic obstructivepulmonarydisease at increased risk of cardiovascular diseases? ... of Disease Study Lancet 1997, 349:1498-1504 Brown CA, Crombie IK, Tunstall-Pedoe H: Failure of cigarette smoking to explain international differences in mortality from chronic obstructivepulmonary ... COPD Chest 2000, 117:5S-9S Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC: Chronic obstructivepulmonarydisease surveillance – United States, 1971–2000 MMWR Surveill Summ 2002, 51:1-16 Zorrilla-Torras...
... chronic obstructivepulmonary disease: Cochrane systematic review and meta-analysis BMJ 2003, 326:185-187 Babu KS, Chauhan AJ: Non-invasive ventilation in chronic obstructivepulmonarydisease ... obstructivepulmonary disease: correlates for success Thorax 1995, 50:755-757 Soo Hoo GW, Santiago S, Williams J: Nasal mechanical ventilation for hypercapnic respiratory failure in chronic obstructive ... ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructivepulmonarydisease Eur Respir 1996, 9:1240-1245 Confalonieri M, Potena A, Carbone G, Della Porta...
... Institute and the World health Organization (đợc biÕt díi tªn Global Initiative for Chronic Obstructive Lung Disease hay GOLD) Nguyễn Đạt Anh 10 Chơng Hô hấp Tóm tắt phác đồ khuyến cáo bN đến khoa...
... Institute and the World health Organization (đợc biết dới tên Global Initiative for Chronic Obstructive Lung Disease hay GOLD) Tãm t¾t phác đồ khuyến cáo bN đến khoa cc trông nặng nhận định cần nhập...
... COPD: Chronic obstructivepulmonary disease; FEV1: Forced expiratory volume in second; FVC: Forced expiratory vital capacity; GOLD: Global initiative for chronic obstructive lung disease; HS: ... Keywords: COPD, Health status, BODE index, dyspnea Introduction Chronic obstructivepulmonarydisease (COPD) has significant extrapulmonary consequences that lead to comorbidity conditions and effects ... between disease markers and health status (HS) overtime is unclear The aim of this study was to verify the predictors of HS at baseline and after three years in Chronic ObstructivePulmonary Disease...
... the diagnosis, management, and prevention of chronic obstructivepulmonarydisease NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary American journal of ... for clinical trials in chronic lung disease Thorax 1987, 42(10):773-778 Standards for the diagnosis and care of patients with chronic obstructivepulmonarydisease American Thoracic Society American ... of discriminative properties among diseasespecific questionnaires for measuring health-related quality of life in patients with chronic obstructivepulmonarydisease American journal of respiratory...
... respiratory disease questionnaire (CRQ) Copd 2005, 2(1):81-89 Lacasse Y, Brosseau L, Milne S, Martin S, Wong E, Guyatt GH, Goldstein RS: Pulmonary rehabilitation for chronic obstructivepulmonarydisease ... 61(3):140-147 Coventry PA, Hind D: Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructivepulmonary disease: Systematic review and meta-analysis Journal ... Society AT, Society ER: Standards for the diagnosis and treatment of patients with chronic obstructivepulmonarydisease [http://www.ersnet.org/lrPresentations/copd/files/main/ index.html] Dahlen I,...